Holen Sie sich die Stockscreener-App
15.09
0.73%
0.11
Handel nachbörslich:
14.95
-0.14
-0.93%
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Warum fällt CC?
Forum
Prognose
Dividendenhistorie
Schlusskurs vom Vortag:
$14.98
Offen:
$14.97
24-Stunden-Volumen:
2.92M
Relative Volume:
0.68
Marktkapitalisierung:
$2.26B
Einnahmen:
$5.75B
Nettoeinkommen (Verlust:
$77.00M
KGV:
30.80
EPS:
0.49
Netto-Cashflow:
$-675.00M
1W Leistung:
+0.13%
1M Leistung:
+23.59%
6M Leistung:
+12.53%
1J Leistung:
-18.56%
1-Tages-Spanne:
$14.65
$15.14
1-Wochen-Bereich:
$14.62
$15.43
52-Wochen-Spanne:
$9.13
$22.38
Chemours Company Stock (CC) Company Profile
Firmenname
Chemours Company
Sektor
Branche
Telefon
302 773 1000
Adresse
1007 MARKET STREET, WILMINGTON, DE
Vergleichen Sie CC mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
CC
Chemours Company
|
15.09 | 2.29B | 5.75B | 77.00M | -675.00M | 0.49 |
|
LIN
Linde plc Ordinary Share
|
472.39 | 222.33B | 33.25B | 6.89B | 5.07B | 14.06 |
|
SHW
Sherwin Williams Co
|
365.78 | 89.99B | 23.08B | 2.54B | 2.15B | 10.08 |
|
ECL
Ecolab Inc
|
274.94 | 77.94B | 15.72B | 2.16B | 1.57B | 7.49 |
|
APD
Air Products Chemicals Inc
|
289.97 | 65.03B | 12.06B | 1.61B | -4.63B | 6.95 |
|
DD
Dupont De Nemours Inc
|
77.15 | 31.73B | 12.61B | 109.00M | 1.32B | -0.47 |
Chemours Company Stock (CC) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-03-27 | Hochstufung | Mizuho | Neutral → Outperform |
| 2025-01-28 | Eingeleitet | Truist | Buy |
| 2024-07-09 | Hochstufung | UBS | Neutral → Buy |
| 2024-06-07 | Eingeleitet | Mizuho | Neutral |
| 2024-04-09 | Hochstufung | BMO Capital Markets | Underperform → Outperform |
| 2024-03-05 | Herabstufung | UBS | Buy → Neutral |
| 2024-02-29 | Herabstufung | BMO Capital Markets | Outperform → Underperform |
| 2023-12-01 | Hochstufung | RBC Capital Mkts | Sector Perform → Outperform |
| 2023-06-22 | Herabstufung | BofA Securities | Buy → Neutral |
| 2023-01-24 | Hochstufung | UBS | Neutral → Buy |
| 2023-01-11 | Hochstufung | BofA Securities | Neutral → Buy |
| 2023-01-10 | Herabstufung | RBC Capital Mkts | Outperform → Sector Perform |
| 2022-11-01 | Eingeleitet | Credit Suisse | Underperform |
| 2022-10-13 | Eingeleitet | Goldman | Neutral |
| 2022-10-05 | Herabstufung | Argus | Buy → Hold |
| 2022-06-14 | Herabstufung | BofA Securities | Buy → Neutral |
| 2021-06-10 | Eingeleitet | Wolfe Research | Outperform |
| 2021-06-09 | Hochstufung | Goldman | Neutral → Buy |
| 2021-05-20 | Eingeleitet | BofA Securities | Buy |
| 2021-05-06 | Hochstufung | Argus | Hold → Buy |
| 2021-01-08 | Hochstufung | RBC Capital Mkts | Sector Perform → Outperform |
| 2020-12-04 | Herabstufung | Barclays | Overweight → Equal Weight |
| 2020-11-30 | Eingeleitet | Alembic Global Advisors | Overweight |
| 2020-03-23 | Herabstufung | Jefferies | Buy → Hold |
| 2020-02-14 | Hochstufung | CFRA | Buy → Strong Buy |
| 2019-11-06 | Hochstufung | CFRA | Hold → Buy |
| 2019-08-20 | Hochstufung | Susquehanna | Neutral → Positive |
| 2019-08-09 | Herabstufung | RBC Capital Mkts | Outperform → Sector Perform |
| 2019-08-06 | Herabstufung | Argus | Buy → Hold |
| 2019-08-05 | Herabstufung | SunTrust | Buy → Hold |
| 2019-07-12 | Herabstufung | Citigroup | Buy → Neutral |
| 2019-05-06 | Herabstufung | JP Morgan | Overweight → Neutral |
| 2019-04-15 | Hochstufung | SunTrust | Hold → Buy |
| 2019-02-19 | Herabstufung | Susquehanna | Positive → Neutral |
| 2019-01-08 | Eingeleitet | HSBC Securities | Buy |
| 2019-01-04 | Hochstufung | Citigroup | Neutral → Buy |
| 2018-11-02 | Herabstufung | Citigroup | Buy → Neutral |
| 2018-07-18 | Eingeleitet | RBC Capital Mkts | Outperform |
| 2018-01-30 | Eingeleitet | Morgan Stanley | Equal-Weight |
| 2017-12-06 | Herabstufung | Goldman | Buy → Neutral |
| 2017-08-07 | Hochstufung | UBS | Sell → Neutral |
Alle ansehen
Chemours Company Aktie (CC) Neueste Nachrichten
The Chemours Company (NYSE:CC) Held Back By Insufficient Growth Even After Shares Climb 33% - simplywall.st
Analyzing The Chemours Company with risk reward ratio chartsMarket Performance Recap & Risk Controlled Stock Alerts - Newser
Chemours Announces Board Appointments with Mary Cranston as Chair and Alister Cowan as Lead Independent Director - AInvest
The Chemours Company Announces Board Appointments - MarketScreener
Is now the right time to enter The Chemours CompanyJuly 2025 Sentiment & Technical Buy Zone Confirmation - khodrobank.com
Chemours appoints Mary Cranston as board chair following leadership change - Investing.com
Chemours appoints new board leadership as chair departs for government role - Investing.com
Is The Chemours Company stock entering bullish territory2025 Growth vs Value & Smart Allocation Stock Reports - Newser
Chemours Appoints New Chair and Lead Director - TipRanks
Chemours Appoints Mary Cranston as Chair - MarketScreener
What to do if you’re stuck in The Chemours CompanyEarnings Miss & Free Reliable Trade Execution Plans - Newser
Chemours names Mary Cranston as Chair of the Board - TipRanks
Chemours Announces Board Leadership Appointments: Mary Cranston Named Chair, Alister Cowan Named Lead Independent Director - Business Wire
How to forecast The Chemours Company trends using time seriesJuly 2025 WrapUp & Risk Adjusted Swing Trade Ideas - Newser
Predicting The Chemours Company trend using moving averages2025 Market WrapUp & Safe Capital Preservation Plans - Newser
Top chart patterns to watch in The Chemours CompanyMarket Growth Summary & Real-Time Volume Analysis - Newser
Will a bounce in The Chemours Company offer an exitAnalyst Upgrade & Verified Swing Trading Watchlists - Newser
What recovery options are there for The Chemours CompanyJuly 2025 Market Mood & Real-Time Volume Trigger Notifications - Newser
Pattern recognition hints at The Chemours Company upsideEarnings Recap Report & Weekly Top Gainers Alerts - Newser
What’s the recovery path for long term holders of The Chemours CompanyJuly 2025 Trade Ideas & Verified Short-Term Trading Plans - Newser
What is The Chemours Company s revenue forecastGlobal Markets & High Win Rate Trade Tips - khodrobank.com
Is The Chemours Company stock bottoming outWeekly Risk Summary & Community Verified Trade Signals - Newser
How to recover losses in The Chemours Company stock2025 Market Sentiment & Safe Entry Trade Reports - Newser
The Chemours Company stock chart pattern explainedJuly 2025 Catalysts & Weekly Chart Analysis and Guides - Newser
Cleanup of Manhattan Project-era radioactive waste at Delaware River site continues in NJ - NJ Spotlight News
Sector ETF performance correlation with The Chemours Company2025 Major Catalysts & Weekly Sector Rotation Insights - Newser
Can you recover from losses in The Chemours CompanyJuly 2025 Market Mood & Risk Controlled Daily Trade Plans - Newser
Is The Chemours Company undervalued by DCF analysisJuly 2025 Movers & Verified Momentum Stock Ideas - khodrobank.com
Does The Chemours Company show high probability of reboundVolume Spike & Precise Buy Zone Identification - Newser
Analyzing The Chemours Company with multi timeframe chartsTrade Signal Summary & Capital Efficient Trading Techniques - Newser
How to monitor The Chemours Company with trend dashboards2025 Major Catalysts & High Conviction Trade Alerts - Newser
Chart based analysis of The Chemours Company trendsPortfolio Risk Summary & Real-Time Volume Trigger Notifications - Newser
Is The Chemours Company in a consolidation phaseJuly 2025 Retail & Community Consensus Stock Picks - khodrobank.com
Chemours in link-up with SRF to supply fluoroelastomers in India - European Rubber Journal
How to integrate The Chemours Company into portfolio analysis toolsEarnings Miss & Smart Allocation Stock Reports - Newser
Real time social sentiment graph for The Chemours CompanyJuly 2025 Reactions & AI Powered Market Entry Ideas - Newser
A | Does The Chemours Company align with a passive investing strategy - خودرو بانک
Will The Chemours Company benefit from government policyJuly 2025 Closing Moves & Reliable Intraday Trade Alerts - خودرو بانک
Intraday pattern recognizer results for The Chemours CompanyWeekly Trade Recap & Fast Entry High Yield Tips - Newser
The Chemours Company stock momentum explainedEarnings Miss & Long-Term Growth Plans - Newser
Is The Chemours Company reversing from oversold territoryWeekly Stock Analysis & Free Fast Gain Swing Trade Alerts - Newser
Has The Chemours Company formed a bullish divergenceEarnings Risk Report & Reliable Volume Spike Alerts - Newser
Order flow analysis tools used on The Chemours CompanyJuly 2025 Big Picture & High Return Stock Watch Alerts - Newser
Evaluating The Chemours Company with trendline analysisMarket Movers & Free Real-Time Volume Trigger Notifications - Newser
Forecasting The Chemours Company price range with options data2025 Support & Resistance & Daily Risk Controlled Trade Plans - Newser
Relative strength of The Chemours Company in sector analysis2025 Pullback Review & Risk Controlled Daily Plans - Newser
Will The Chemours Company bounce back from current supportMarket Activity Report & Real-Time Market Trend Scan - Newser
Using Ichimoku Cloud for The Chemours Company technicalsWeekly Stock Analysis & Technical Pattern Based Signals - Newser
The Chemours Company (NYSE:CC) Surges 34% Yet Its Low P/S Is No Reason For Excitement - 富途牛牛
Finanzdaten der Chemours Company-Aktie (CC)
Umsatz
Nettogewinn
Free Cashflow
ENV
3.53%
0.27%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):